Literature DB >> 8878348

The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task.

H Meziane1, C Mathis, S M Paul, A Ungerer.   

Abstract

The effects of the neurosteroid pregnenolone sulfate (PS) on learning as well as on scopolamine-induced learning deficits were studied in Swiss mice using an appetitively reinforced Go-No Go visual discrimination task. Subcutaneous (SC) administration of scopolamine (0.3-3 mg/kg) after the first session of training dose-dependently impairs learning during the following sessions in this task. Moreover, intracerebroventricular (ICV) administration of PS (0.01-10 nmol) dose-dependently blocks learning deficits induced by scopolamine (3 mg/kg), with the most potent effects at the dose of 0.5 nmol PS. In addition to antagonizing the amnestic effects of scopolamine, PS (0.5 nmol ICV) has a memory-enhancing effect, when administered alone after the first training session. Scopolamine (3 mg/kg SC) also produced substantial deficits on retrieval performance in the Go-No Go visual discrimination task, and caused motor disturbances, when administered 15 min before testing. PS (0.5 nmol ICV) also reduced scopolamine-induced deficits on retrieval but had no effect on scopolamine-induced motor impairments in the traction reflex test. Such a rapid effect of PS on memory processes may be mediated via NMDA and/or GABAA receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878348     DOI: 10.1007/bf02247383

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Pharmacological mechanisms and animal models of cognition.

Authors:  G.R. Dawson; C.M. Heyes; S.D. Iversen
Journal:  Behav Pharmacol       Date:  1992-08       Impact factor: 2.293

Review 2.  The central cholinergic system during aging.

Authors:  G Pepeu; L Giovannelli
Journal:  Prog Brain Res       Date:  1994       Impact factor: 2.453

Review 3.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

4.  Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.

Authors:  H V Curran; F Schifano; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.

Authors:  M R Bowlby
Journal:  Mol Pharmacol       Date:  1993-05       Impact factor: 4.436

6.  Neurosteroids block the memory-impairing effects of ethanol in mice.

Authors:  C L Melchior; R F Ritzmann
Journal:  Pharmacol Biochem Behav       Date:  1996-01       Impact factor: 3.533

7.  Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

Authors:  J F Flood; J E Morley; E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

Authors:  W W Beatty; N Butters; D S Janowsky
Journal:  Behav Neural Biol       Date:  1986-03

9.  Pregnenolone and its sulfate ester in the rat brain.

Authors:  C Corpéchot; M Synguelakis; S Talha; M Axelson; J Sjövall; R Vihko; E E Baulieu; P Robel
Journal:  Brain Res       Date:  1983-06-27       Impact factor: 3.252

10.  Memory and cognitive function in man: does the cholinergic system have a specific role?

Authors:  D A Drachman
Journal:  Neurology       Date:  1977-08       Impact factor: 9.910

View more
  15 in total

Review 1.  Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

Authors:  Olivier George; Monique Vallée; Michel Le Moal; Willy Mayo
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

Review 2.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

3.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

4.  The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?

Authors:  Y Akwa; N Ladurelle; D F Covey; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

6.  Low concentrations of neuroactive steroids alter kinetics of [3H]ifenprodil binding to the NMDA receptor in rat frontal cortex.

Authors:  Tobias Johansson; Per-Anders Frändberg; Fred Nyberg; Pierre Le Grevès
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

7.  Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse.

Authors:  T Maurice; V L Phan; A Urani; I Guillemain
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

8.  Receptor protein tyrosine phosphatase gamma is a marker for pyramidal cells and sensory neurons in the nervous system and is not necessary for normal development.

Authors:  Smaragda Lamprianou; Nathalie Vacaresse; Yoshihisa Suzuki; Hamid Meziane; Joseph D Buxbaum; Joseph Schlessinger; Sheila Harroch
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

9.  The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors.

Authors:  Takafumi Horishita; Kouichiro Minami; Yasuhito Uezono; Munehiro Shiraishi; Junichi Ogata; Takashi Okamoto; Tadanori Terada; Takeyoshi Sata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-03-19       Impact factor: 3.000

10.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.